{"title":"A study of pharmacokinetic of rifapentine combined with isoniazid in the preventive treatment of tuberculosis in silicotic patients","authors":"Qing-luan Yang, Qi-hui Liu, Miao-yao Lin, Yuzhen Xu, Xue-feng Liu, Zhangdong He, Xi-tian Huang, B. Hao, L. Shao, Wenhong Zhang, Qiaoling Ruan","doi":"10.3969/J.ISSN.1000-6621.2021.03.007","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":9891,"journal":{"name":"中国防痨杂志","volume":"43 1","pages":"228"},"PeriodicalIF":0.0000,"publicationDate":"2021-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"中国防痨杂志","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3969/J.ISSN.1000-6621.2021.03.007","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
期刊介绍:
Chinese Journal of Antituberculosis (Editor-in-Chief: Wang Lixia; ISSN 1000-6621, CN 11-2761/R) is published monthly in Chinese by the Chinese Antituberculosis Association, and is a peer reviewed medical journal for doctors, medical researchers, and health workers in the field of tuberculosis. The journal reports the advances and progress in current tuberculosis sciences and technology.